ChristopherDvorakMD

Pediatric Hematology & Oncology • Palo Alto, CA

Professor, Pediatrics, UCSF School of Medicine

Join to view full profile

Dr. Dvorak is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Dvorak's full profile

Already have an account?

Office
725 Welch Rd
Palo Alto, CA 94304
Phone+1 650-723-4000

Education & Training

Stanford Health Care-Sponsored Stanford UniversityFellowship, Pediatric Hematology/Oncology, 2002 - 2005
Stanford Health Care-Sponsored Stanford UniversityResidency, Pediatrics, 1998 - 2001
Vanderbilt University School of MedicineClass of 1998

Certifications & Licensure

CA State Medical License 1999 - 2026
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Stem Cell Related Donor Safety Study Start of enrollment: 2010 Jan 01
Completed
Hematopoietic Stem Cell Transplantation (HSCT) for Children With SCID Utilizing Alemtuzumab, Plerixafor & Filgrastim Start of enrollment: 2010 Aug 01
Terminated
Phase 2
Expanded Access Protocol (EAP) Using the CliniMACS® Device for Pediatric Haplocompatible Donor Stem Cell Transplant
No longer available
Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation Start of enrollment: 2011 Sep 01
Completed
Phase 3
MRD Testing Before and After Hematopoietic Cell Transplantation for Pediatric Acute Myeloid Leukemia Start of enrollment: 2011 Oct 01
Completed
Caspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients Following Donor Stem Cell Transplant Start of enrollment: 2013 Mar 21
Completed
Phase 3
Pilot Trial of Clofarabine Added to Standard Busulfan and Fludarabine for Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation Start of enrollment: 2012 May 24
Terminated
Phase 2
Long Term Effects On Recipients of Hematopoietic Stem Cell Transplantation Start of enrollment: 1995 Jan 01
Recruiting
Chlorhexidine Gluconate Cleansing in Preventing Central Line Associated Bloodstream Infection and Acquisition of Multi-drug Resistant Organisms in Younger Patients With Cancer or Undergoing Donor Stem Cell Transplant Start of enrollment: 2013 Nov 04
Completed
Phase 3
Busulfan, Cyclophosphamide, and Melphalan or Busulfan and Fludarabine Phosphate Before Donor Hematopoietic Cell Transplant in Treating Younger Patients With Juvenile Myelomonocytic Leukemia Start of enrollment: 2013 Jun 24
Completed
Phase 2
JSP191 Antibody Targeting Conditioning in SCID Patients Start of enrollment: 2017 Mar 20
Recruiting
Phase 1, Phase 2
Defibrotide TMA Prophylaxis Pilot Trial Start of enrollment: 2018 May 01
Completed
Phase 2
Identifying Predictors of Poor Health-Related Quality-of-Life Among Pediatric Hematopoietic Stem Cell Donors Start of enrollment: 2019 Apr 03
Active, not recruiting
Roles: Principal Investigator, Contact
A Feasibility Study Using CLINIMACS® for Alpha/Beta T-Cell Depletion in Stem Cell Transplant Start of enrollment: 2019 Dec 19
Recruiting
Not Applicable
Roles: Contact, Sponsor-Investigator, Principal Investigator
Conditioning SCID Infants Diagnosed Early Start of enrollment: 2018 Oct 22
Recruiting
Phase 2
Roles: Contact, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

13 citations
Simultaneous determination of fludarabine and clofarabine in human plasma by LC-MS/MS.
Liusheng Huang, Patricia Lizak, Christopher C. Dvorak, Francesca T. Aweeka, Janel Long-Boyle
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 2014-06-01
61 citations
The incidence, mortality and timing of Pneumocystis jiroveci pneumonia after hematopoietic cell transplantation : A CIBMTR analysis
Kirsten M. Williams, Kwang Woo Ahn, Min Chen, Mahmoud Aljurf, Allison L. Agwu
Bone Marrow Transplantation. 2016-04-01
16 citations
Comparison of hematopoietic cell transplant conditioning regimens for hemophagocytic lymphohistiocytosis disorders
Rebecca A. Marsh, Kyle Hebert, Soyoung Kim, Christopher C. Dvorak, Victor M. Aquino
The Journal of Allergy and Clinical Immunology. 2021-08-08

Journal Articles

Related Peripheral Blood Stem Cell Donors Experience More Severe Symptoms and Less Complete Recovery at 1-Year Compared to Unrelated Donors
Parameswaran N Hari, David A Jacobsohn, Joseph P McGuirk, Mary M Horowitz, Walter Longo, Thomas Spitzer, Daniel J Weisdorf, Shahram Mori, David C Delgado, Marcie L Ric..., Haematologica
Effect of Levofloxacin Prophylaxis on Bacteremia in Children with Acute Leukemia or Undergoing Hematopoietic Stem Cell Transplantation
L Charles Bailey, Aditya H Gaur, Michael L Nieder, Michael Green, Christopher C Dvorak, JAMA
Veno-Occlusive Disease After High-Dose Busulfan–Melphalan in Neuroblastoma
Gregory Yanik, Morris Kletzel, Stephan Grupp, David Jacobsohn, Christopher C Dvorak, Alix E Seif, Mark Ranalli, Haydar Frangoul, Nature

Abstracts/Posters

Non-Genotoxic Anti-CD117 Antibody Conditioning Results in Successful Hematopoietic Stem Cell Engraftment in Patients with Severe Combined Immunodeficiency
Christopher C. Dvorak, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Reduced Toxicity Conditioning for Non-Malignant Hematopoietic Cell Transplants
Christopher C. Dvorak, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Next Generation Sequence Minimal Residual Disease (NGS-MRD) Predicts Outstanding Event Free Survival (EFS) Regardless of Hematopoietic Cell Transplantation (HCT) Prepa...
Christopher C. Dvorak, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Role of Disease Mechanism in Hematopoietic Cell Transplantation Outcomes for Hemophagocytic Lymphohistiocytosis
Christopher C. Dvorak, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Join now to see all

Lectures

Incidence and Cost of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome with and without Multi-Organ Dysfunction: Analysis of the Premier Healthcare Database
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Career-Development Lunch Sessions: Pediatric Clinical Malignant Hematology/BMT
60th American Society of Hematology Annual Meeting - 12/1/2018

Press Mentions

Gene Therapy May Reverse Hurler Syndrome, a Rare and Severe Illness in KidsNovember 18th, 2021